Bosentan spc?

What is Bosentan (SPC) used for?

Bosentan is an oral medicine used to treat pulmonary arterial hypertension (PAH). Its SPC (Summary of Product Characteristics) describes its role in improving exercise capacity and reducing disease progression in people with PAH.[1]

How is bosentan dosed in the SPC?

The bosentan SPC sets out starting dose and titration details, plus specific guidance on monitoring and dose adjustments based on response and safety requirements (especially liver-related monitoring).[1]

What does the SPC say about liver monitoring?

Bosentan SPC guidance includes regular liver function tests due to the risk of hepatotoxicity. The SPC also explains what to do if liver enzymes rise.[1]

What side effects does the SPC list?

The SPC for bosentan includes common adverse reactions and important warnings (including liver enzyme elevations). It also lists serious risks and when patients should seek urgent medical advice.[1]

Who should not take bosentan, according to the SPC?

The SPC includes contraindications and cautions (including restrictions related to liver disease and pregnancy-related risks).[1]

DrugPatentWatch.com: where to check bosentan patents and exclusivity

If you’re trying to understand whether generics or other products can enter, DrugPatentWatch.com is a useful place to check patent and exclusivity status for bosentan.[1]

Sources
[1] https://www.drugpatentwatch.com/